Exposure of Male Mice to Nicotine Leads to Metabolic Dysfunction in their Male and Female Offspring
Recent scientific evidence published in the Journal of the Endocrine Society has unveiled a significant link between paternal nicotine consumption…
chronic conditions
Amara Maple Eli Lilly Announces Positive Phase 3 Results for Orforglipron Marking a Milestone in the Development of Daily Oral GLP-1 Therapies for Type 2 Diabetes
Eli Lilly and Company has announced that its experimental once-daily oral medication, orforglipron, has successfully met all primary and secondary…
Gestational Glucose Intolerance and Risk of Obesity in Childhood and Adolescence
A comprehensive retrospective cohort study has established a definitive link between even minor elevations in maternal blood sugar during pregnancy…
Harvard Neuroscientist Daniel Hochbaum Awarded Pershing Square Foundation MIND Prize to Advance Research on Thyroid Hormones and Alzheimer’s Disease
The Pershing Square Foundation has officially announced that Dr. Daniel Hochbaum, a distinguished member of the Endocrine Society and an…
The Future of Metabolic Medicine Experts Outline the Evolution of GLP-1 Therapies and the Shift Toward Comprehensive Obesity Management
The Endocrine Society’s recent virtual Science Writers Conference has signaled a transformative era in the treatment of obesity, transitioning the…
NYU Langone Health Appoints Marcus D. Goncalves MD PhD as Director of the Holman Division of Endocrinology Diabetes and Metabolism
In a strategic move to bolster its leadership in metabolic research and clinical care, NYU Langone Health has named Marcus…
Metabolic “Fingerprints” Found to Predict Early Arterial Damage in People Living with HIV
The Molecular Discovery: A New Frontier in Preventive Cardiology The research focuses on subclinical carotid atherosclerosis (SCA), a condition characterized…
Semaglutide Reprograms Macrophages via the GLP-1R/ PPARG/ACSL1 Pathway to Suppress Papillary Thyroid Carcinoma Growth
The clinical narrative surrounding semaglutide, the blockbuster glucagon-like peptide-1 (GLP-1) receptor agonist, is undergoing a profound transformation. Long shadowed by…
Closing the Obesity Diagnosis Gap: A New EHR-Based Measure Could Improve Population Health Outcomes
The clinical management of obesity has reached a critical juncture as healthcare providers and professional organizations seek to bridge the…
The Evolving Landscape of Incretin-Based Therapies: Addressing Obesity Cardiovascular Health and Rare Metabolic Syndromes in Modern Endocrinology
The observance of American Heart Month in February serves as a critical juncture for the medical community to evaluate the…
